-
Arch Biopartners Closes Non-Brokered Private Placement
19 Nov 2025 21:27 GMT
… been generally disclosed. About Arch Biopartners Arch Biopartners Inc. is a therapeutic … Benson
Director of Communications
Arch Biopartners, Inc.
647-428-7031
Send … . Additional information relating to Arch Biopartners Inc., including the Company’s …
-
People: Love2shop; Panthera Biopartners; Savills; Palatine; English Lakes Hotels Culinary Academy; Xeinadin
14 Nov 2025 07:57 GMT
Alex Speed
Liverpool-based Love2shop, part of the PayPoint Group, has appointed Alex Speed as its new sales director, marking a new chapter of growth and innovation for the multi-retailer gift card and digital rewards brand.
Alex succeeds Frank Creighton, …
-
Mark Egerton Appointed Chairman of Panthera Biopartners
13 Nov 2025 04:39 GMT
Panthera Biopartners, a UK Site Management Organization ( … join the board of Panthera Biopartners. The management team has done … the UK and Europe”.
Panthera Biopartners was founded in 2019 and …
-
Arch Biopartners Arranges Non-Brokered Private Placement
10 Nov 2025 13:10 GMT
… been generally disclosed. About Arch Biopartners Arch Biopartners Inc. is a therapeutic … Benson
Director of Communications
Arch Biopartners, Inc.
647-428-7031
Send … . Additional information relating to Arch Biopartners Inc., including the Company’s …
-
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
05 Nov 2025 13:30 GMT
… (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the … 2026. About Arch Biopartners Arch Biopartners Inc. is a therapeutic … Director of Communications
Arch Biopartners Inc.
647-428-7031 … information relating to Arch Biopartners Inc., including the Company …
-
LDC takes stake in Panthera Biopartners to drive expansion
12 Aug 2025 08:11 GMT
… acquired a stake in Panthera Biopartners, the UK’s largest site …
-
LDC pumps capital into UK’s Panthera Biopartners
12 Aug 2025 09:52 GMT
-
Arch Biopartners begins patient dosing at Toronto General Hospital in phase II trial of LSALT peptide targeting cardiac surgery-associated acute kidney injury
07 Aug 2025 13:16 GMT
Arch Biopartners Inc. (Arch), a late-stage … ,” said Richard Muruve, CEO, Arch Biopartners.
The CS-AKI phase II … this high-risk population.
Arch Biopartners Inc. is a late-stage …
-
Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury
06 Aug 2025 11:25 GMT
… (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “ … risk population. About Arch Biopartners Arch Biopartners Inc. is a …
Director of Communications
Arch Biopartners, Inc.
647-428- … information relating to Arch Biopartners Inc., including our most …
-
On this day: Panthera Biopartners research site opens in York
30 Jul 2025 04:23 GMT
Based at Acomb Garth Community Centre, the site had been operational since May 2024.
It had just had its official launch, conducted by the Lord Mayor of York, councillor Margaret Wells.
The site, operated by primary care provider Nimbuscare, was said to …
About
© 1995-2025